Physician profile
Chom Phou Nguyen
NPI 1427669357
$1,500.21
in general payments reported to CMS, 2019-2025
21 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $422 · 2024: $679 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,500.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $322.31 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.46 | 2023-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.86 | 2023-2025 | Jardiance |
| Edwards Lifesciences Corporation | $88.59 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Esperion Therapeutics, INC. | $86.77 | 2024-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $75.19 | 2023-2024 | Farxiga |
| Amgen INC. | $67.13 | 2024-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $67.10 | 2023-2024 | Xarelto |
| Heartflow, INC. | $58.21 | 2023-2025 | Ffrct |
| Alnylam Pharmaceuticals INC. | $57.93 | 2024-2025 | Amvuttra |
| Cvrx, INC. | $50.64 | 2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $43.30 | 2024-2025 | |
| Pfizer INC. | $42.71 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $40.52 | 2023-2024 | Evkeeza |
| Merck Sharp & Dohme LLC | $36.18 | 2023-2024 | Verquvo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vital Connect, INC | $22.97 | 2025 | Vitalpatch Rtm |
| Sanofi-Aventis U.S. LLC | $22.67 | 2024 | |
| Baxter Healthcare | $18.81 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Tactile Systems Technology INC | $17.73 | 2025 | Flexitouch Plus, Nimbl |
| Actelion Pharmaceuticals US, INC. | $14.34 | 2025 | Uptravi, Opsumit |
| Scpharmaceuticals INC. | $13.79 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chom Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.